Optimizing Biomarker Testing in Your Practice: Leveraging In-House Testing Strategies - Episode 9
Impact of In-House Testing on Improved Cancer Care: Timely Decisions and Enhanced Treatment Accuracy
Panelists discuss how in-house laboratory testing has demonstrated significant advantages in patient care through rapid turnaround times and immediate decision-making capabilities. Emergency departments have seen notably improved outcomes when critical tests like cardiac markers and blood gases are performed on-site, enabling faster treatment initiation for acute conditions. For example, rapid troponin testing in-house allows for immediate cardiac intervention decisions, while stat electrolyte panels enable quick medication adjustments for critical patients. Additionally, on-site therapeutic drug monitoring helps clinicians make real-time dosing modifications, which is particularly beneficial for antibiotics and anticoagulation therapy.
Video series above is prompted by the following:
- Can you share any examples of when in-house testing provided improved care over send-out testing?
- Share specific scenarios where in-house testing resulted in quicker treatment initiation or more accurate treatment decisions.
Related Content:
